Total Payments
$412,954
2024 Payments
$80,693
Companies
27
Transactions
975
Payment Breakdown by Category
Other$353,656 (85.6%)
Consulting$20,516 (5.0%)
Food & Beverage$20,371 (4.9%)
Travel$18,392 (4.5%)
Education$19.21 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $350,906 | 169 | 85.0% |
| Consulting Fee | $20,516 | 6 | 5.0% |
| Food and Beverage | $20,371 | 680 | 4.9% |
| Travel and Lodging | $18,392 | 115 | 4.5% |
| Honoraria | $2,750 | 1 | 0.7% |
| Education | $19.21 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $118,946 | 154 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $112,333 | 170 | $0 (2024) |
| ABBVIE INC. | $52,732 | 127 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $50,430 | 94 | $0 (2024) |
| Ironshore Pharmaceuticals Inc. | $29,379 | 60 | $0 (2020) |
| Alkermes, Inc. | $25,549 | 67 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $11,087 | 6 | $0 (2024) |
| Corium, LLC | $4,006 | 15 | $0 (2024) |
| Allergan, Inc. | $3,732 | 50 | $0 (2020) |
| Lundbeck LLC | $921.14 | 57 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $80,693 | 170 | Otsuka America Pharmaceutical, Inc. ($31,749) |
| 2023 | $95,084 | 168 | AbbVie Inc. ($31,315) |
| 2022 | $61,030 | 112 | Otsuka America Pharmaceutical, Inc. ($29,009) |
| 2021 | $77,356 | 103 | Neurocrine Biosciences, Inc. ($33,540) |
| 2020 | $8,789 | 64 | Otsuka America Pharmaceutical, Inc. ($5,496) |
| 2019 | $54,365 | 168 | Ironshore Pharmaceuticals Inc. ($29,354) |
| 2018 | $16,564 | 101 | Alkermes, Inc. ($8,032) |
| 2017 | $19,074 | 89 | Alkermes, Inc. ($16,737) |
All Payment Transactions
975 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: CNS | ||||||
| 12/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/26/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: CNS | ||||||
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,548.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $34.03 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Insomnia | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $20.24 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.26 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,548.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/11/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/11/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Travel and Lodging | In-kind items and services | $101.84 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/11/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Travel and Lodging | In-kind items and services | $52.26 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/11/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Travel and Lodging | In-kind items and services | $49.33 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/11/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Travel and Lodging | In-kind items and services | $49.33 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/11/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $37.45 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/11/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Travel and Lodging | In-kind items and services | $139.36 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
About Dr. Gregory Brown, M.D
Dr. Gregory Brown, M.D is a Psychiatry healthcare provider based in Shreveport, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821058181.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Brown, M.D has received a total of $412,954 in payments from pharmaceutical and medical device companies, with $80,693 received in 2024. These payments were reported across 975 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($350,906).
Ad
Practice Information
- Specialty Psychiatry
- Location Shreveport, LA
- Active Since 03/23/2006
- Last Updated 04/24/2018
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1821058181
Products in Payments
- INGREZZA (Drug) $118,946
- REXULTI (Drug) $112,198
- VRAYLAR (Drug) $56,463
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $29,354
- Aristada 441 mg (Drug) $24,769
- Qelbree (Drug) $24,279
- QELBREE (Drug) $23,061
- QUVIVIQ (Drug) $11,087
- AZSTARYS (Drug) $3,716
- ABILIFY MAINTENA (Drug) $1,140
- LATUDA (Drug) $907.74
- CAPLYTA (Drug) $880.78
- ARISTADA (Drug) $779.51
- TRINTELLIX (Drug) $551.22
- VYVANSE (Drug) $513.52
- Azstarys (Drug) $290.33
- Auvelity (Drug) $191.34
- MYDAYIS (Drug) $181.93
- INVEGA SUSTENNA (Drug) $156.68
- Adzenys XR-ODT (Drug) $48.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Shreveport
Dr. Jasjit Singh, Md, MD
Psychiatry — Payments: $302,323
Psychiatry $302,323
Suresh Sabbenahalli, Md, MD
Psychiatry — Payments: $9,973
Psychiatry $9,973
Dr. Daniel Feeney, M.d, M.D
Psychiatry — Payments: $4,529
Psychiatry $4,529
Kathryn Kennedy, Md, MD
Psychiatry — Payments: $3,662
Psychiatry $3,662
Elizabeth Bright, Aprn, APRN
Psychiatry — Payments: $3,114
Psychiatry $3,114
Anand Bosmia, Md, MD
Psychiatry — Payments: $2,659
Psychiatry $2,659